Chronic myeloid leukemia (CML) is characterized by the presence of BCR::ABL1 fusion gene resulting from a reciprocal translocation, t(9;22)(q34;q11.2), leading to prominent granulocytic proliferation. This evidence concerns the gene BCR and chronic myelogenous leukemia, BCR-ABL1 positive.